Navigation Links
Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
Date:10/12/2011

EAST BRUNSWICK, N.J., Oct. 12, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the company will release financial results for the third quarter 2011 prior to the open of the market on Thursday, November 3, 2011.

John H. Johnson, Chief Executive Officer and President, and Kenneth J. Zuerblis, Executive Vice President and Chief Financial Officer, will host an investment community conference call beginning at 9:00 a.m. Eastern Time on November 3, 2011 to discuss these results and to answer questions.

To participate by telephone, please dial 866-393-9370 (Domestic) or 706-679-1207 (International). The conference ID number is 17722127. The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com. Please log on to Savient's website fifteen minutes prior to the start of the call to ensure adequate time for any downloads that may be necessary.

A telephone replay will be available from 12:00 p.m. Eastern Time on November 3, 2011 through 12:00 a.m. Eastern Time on November 17, 2011 by dialing 855-859-2056 (Domestic), alternate number 800-585-8367 or 404-537-3406 (International) and entering conference ID number 17722127.

About Savient Pharmaceuticals, Inc.Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA.  MVP and Duke have been grant
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... India , September 4, 2015 ... Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) ... Technology and by Product - Global Forecast to 2020", ... to reach USD 2.5 Billion by 2020, growing at ... 2015 to 2020. Browse 139 Tables ...
(Date:9/4/2015)... -- Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi , ... September 10, 2015. DATE: Thursday, September 10, ... This will be a live, ... the company questions in real-time - both in the ... booth." If attendees are not able to join the ...
(Date:9/4/2015)...  Allergan plc (NYSE: AGN ) a leading global ... and President of Allergan, will provide an overview and update ... Conference 2015 in New York, NY . ... The presentation will take place on Thursday, September 17, 2015 ... York, 109 East 42nd Street, New York, NY ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
... March 7, 2012  Prime Therapeutics (Prime), a leading pharmacy ... in the U.S. biopharmaceutical market and subsidiary of Merck ... the first outcomes-based rebate contract for a multiple sclerosis ... integrated PBM with its health plan clients, Prime is ...
... 7, 2012 Denise Noyer-Erez, L.Ac. and Associates are ... all those affected by the disease. This ... in the United States.  In most cases, endometriosis can ... which the endometrium—uterine lining—moves outside the uterus and implants ...
Cached Medicine Technology:Prime Therapeutics Announces CareCentered Contract™ with EMD Serono, Inc. for MS Drug Rebif® 2March is Endometriosis Awareness Month 2
(Date:9/4/2015)... Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... material has been developed that changes color when subjected to an impact force that ... notes, could be implemented in helmets or other sporting equipment so that coaches or ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mile High Connects today releases “First and ... of funding for sidewalks, bike paths, and other vital supports severely limit access to ... spends billions of dollars to expand public transit, there’s very little support for safe ...
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, a locally ... effort to provide for the family of Grace, a young local girl battling ... often leads to diastolic dysfunction – the inability to adequately move blood through ...
(Date:9/4/2015)... Texas (PRWEB) , ... September 04, 2015 , ... ... recipient of three separate “Partner of the Year” awards at this year’s Microsoft ... being named Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform ...
(Date:9/4/2015)... Dallas, TX (PRWEB) , ... September 04, 2015 , ... ... in Iraq in 2007, will compete in the Ironman World Championships in Kona on ... veterans who have incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Missed Connections in Metro Denver Transit 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2
... Nov. 10 ChromaDex (OTC,Bulletin Board: CDXC), today ... with Cargill (Wayzata, Minn.) to supply global,analytical reference ... of stevia. This provides the ability for food ... consumer products., With the introduction of Truvia(TM) ...
... SAN DIEGO, Nov. 10 Favrille, Inc. ... a pure-play,health information company focused on secure ... announced today the signing of a,definitive merger ... on,continuing to build and develop the MyMedicalRecords.com ...
... SAN DIEGO, Nov. 10 After two ... medicine, mind-body physiology,nutrition, and holistic clinical care, ... of credentials the completion of a prestigious ... Launched in 2000 by,internationally-recognized integrative medicine pioneer ...
... Nov. 10 Dr. James Cook, president of,the American ... holiday tradition -- treating pets that have become sick ... into New Years, we,ll see it,every year at my ... Cook explains. "People want to involve their pets in ...
... project coupled with phenomenal growth in large-scale applications such as combinatorial ... highly specialized laboratory equipment. Global Pipettes and Pipettors market is projected ... ... Jose, CA (PRWEB) November 10, 2008 -- Pipettes and pipettors are ...
... rise in the number of laboratories, and lab ... is projected to reach $84.9 million by the ... America hold strong potential for future growth, given ... instruments in these markets. Quality, durability, efficiency, and ...
Cached Medicine News:Health News:ChromaDex Partners With Cargill to Provide Global Quality Control Methods and Standards for Sweet Components of Stevia 2Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 2Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 3Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 4Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 5Health News:Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement 6Health News:Andrew Weil's Integrative Medicine Program Bestows Honors on Chopra Center's Director of Women's Health: Valencia Porter, M.D. receives Integrative Medicine Fellowship 2Health News:AVMA's Top Ten List on Holiday Pet Health 2Health News:Global Pipettes and Pipettors Market to Reach $996.2 Million by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:Global Pipettes and Pipettors Market to Reach $996.2 Million by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:World Laboratory Washing Machines Market to Reach $84.9 Million by 2012, According to New Report by Global Industry Analysts 2Health News:World Laboratory Washing Machines Market to Reach $84.9 Million by 2012, According to New Report by Global Industry Analysts 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: